Current surgical strategies for metastatic melanoma

Current surgical strategies for metastatic melanoma

Publication date: May 05, 2021

Piotr Rutkowski, MD, PhD, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, summarizes his highlights from a symposium on surgery for metastatic melanoma during the 2021 World Congress of Melanoma. He discusses the importance of sentinel node biopsy in the staging of melanoma and how the surgical approach has recently changed based on the results of the DeCOG-SLT (NCT02434107) and MSLT-II (NCT00297895) trials. In addition, Dr. Rutkowski discusses treatment options for in-transit and stage IV metastatic melanoma, as well as the potential role of neoadjuvant therapy. This interview took place during the 10th World Congress of Melanoma in conjunction with the 17th EADO Congress Interactive Virtual Meeting.

Concepts Keywords
Biopsy Clinical medicine
Chemotherapy Immunotherapy
Milan Chemotherapy
Nct02434107 Neoadjuvant therapy
Phd Surgery surgery
Poland Limited respectable disease
Surgery Originally advanced melanoma
Metastases
Medical specialties
Breast cancer
Melanoma
Anatomical pathology
Adjuvant therapy
Sentinel lymph node
Immunotherapy
Cancer staging
Biopsy
Ultrasound
Chemotherapy

Semantics

Type Source Name
disease MESH melanoma
pathway KEGG Melanoma
disease MESH biopsy

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *